FDA gives Sanofi’s experimental hemophilia A drug a Breakthrough Therapy designation
Sanofi said Wednesday that the Food and Drug Administration granted a Breakthrough Therapy designation to the hemophilia A treatment it's developing with Swedish Orphan Biovitrum...